Sector: MedicalAbbott Laboratories (NYSE: ABT)
Ranking History
Scan Date: | 11/24/2009 |
Sector: | Medical |
Funamental : | 45 |
Technical : | 130 |
Performance : | 137 |
Overall: | 62 |
Number of Stocks: | 308 |
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 45 |
Technical : | 38 |
Performance : | 152 |
Overall: | 25 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 46 |
Technical : | 119 |
Performance : | 142 |
Overall: | 62 |
Number of Stocks: | 306 |
Headlines
- Absolute Software Acquires LANrev product suite from Pole Position Software
Dec 03, 2009 08:02 AM | AAPL, ABT, DELL, GD, HPQ, LNVGY
- Abbott and the Abbott Fund Honored With Corporate Citizenship Award for International Community Service
Dec 02, 2009 03:45 PM | ABT
- Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
Dec 02, 2009 01:00 PM | ABT
- Goldman Sachs Removes Abbott and Eli Lilly from "Conviction" Lists (ABT, LLY)
Dec 01, 2009 05:50 PM | ABT, GS, LLY
- Invest In HealthCare!
Dec 01, 2009 12:57 PM | ABT, ACL, ADP, AMGN, AZN, BAX
- Diabetes Care: Global Investing Opportunities
Nov 22, 2009 11:28 PM | ABT, ACCP, ALKS, AMLN, ASX, BDX
- The Deal LLC Announces Winners of the Second Annual Most Admired Corporate Dealmakers Awards
Nov 19, 2009 04:14 PM | ABT, CBS.A, CSCO, DIS, JNJ, MSFT
- The Deal Names Abbott Top Dealmaker for Second Consecutive Year
Nov 19, 2009 02:00 PM | ABT
- WeatherBug Names New Members to Advertising Sales Team
Nov 19, 2009 11:57 AM | ABT, EXPE, IACI, MSFT, SI
- Epinex Diagnostics: A New Paradigm For Diabetic Testing
Nov 19, 2009 11:24 AM | ABT, JNJ
- Beware, many stolen computers have tracking software
Nov 09, 2009 06:57 PM | ABT, BBY
- Beware, Many Stolen Computers Have Tracking Software
Oct 26, 2009 10:55 AM | ABT, BBY
- Boston Scientific returns to profit in 3rd qtr
Oct 19, 2009 07:52 PM | ABT, BSX, STJ
- Sliding Dollar May Be Something to Cheer About
Oct 16, 2009 01:51 PM | ABT, PG
- Abbott Reports Earnings Gain on Stronger Sales, Settlement of Patent Suit: W.W. Grainger Reports Revenue Continues to Fall
Oct 15, 2009 05:55 AM | ABT, ACAS, GWW, MDT
- Abbott Profit Up 37% on Patent Settlement, Humira Sales
Oct 14, 2009 03:11 PM | ABT, MDT
- Humira and nutrition sales lift Abbott 3Q profit
Oct 14, 2009 12:51 PM | ABT, JNJ
- St. Louis Post-Dispatch, David Nicklaus Column
Oct 04, 2009 03:56 PM | ABT, XRX
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 01:17 PM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 06:13 AM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney& a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies
Nov 30, 2009 09:50 AM | ABT, DGX, GS
- Morgan Joseph Names Bruce D. Jackson a Senior Vice President in Equity Research Covering the Medical Device Industry
Nov 18, 2009 10:55 AM | ABT, HCSG, RY
- PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
Nov 12, 2009 09:51 AM | ABT
- Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets
Oct 30, 2009 10:52 AM | ABT, IPXL
- Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
Oct 19, 2009 09:53 AM | ABT, CLRT, DGX, IART, PFE
- Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
Aug 27, 2009 09:01 AM | ABT
- Medtronic Reports First Quarter Revenue of $3.9 Billion
Aug 25, 2009 07:57 AM | ABT, MDT
- Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Aug 24, 2009 09:01 AM | ABT
- Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
Aug 18, 2009 09:01 AM | ABT
- StreetSmart Strategies®, a Management Consulting Firm, Retains Veteran Corporate Investor Relations Officer David Prichard
Aug 18, 2009 07:52 AM | ABT, BG, C, CPO, MOD
- Form 4 ABBOTT LABORATORIES For: Nov 24 Filed by: Mason Heather L (10K)
Nov 25, 2009 06:16 PM
- Form 4 ABBOTT LABORATORIES For: Oct 01 Filed by: WHITE MILES D (10K)
Nov 20, 2009 08:31 PM
- Form 4 ABBOTT LABORATORIES For: Nov 18 Filed by: Fussell Stephen R (10K)
Nov 19, 2009 07:21 PM
- Form 4 ABBOTT LABORATORIES For: Nov 12 Filed by: Bohuon Olivier (10K)
Nov 13, 2009 07:03 PM
- Form 4 ABBOTT LABORATORIES For: Oct 22 Filed by: Landgraf John C (10K)
Nov 13, 2009 06:49 PM
- Form 4 ABBOTT LABORATORIES For: Nov 11 Filed by: FREYMAN THOMAS C (10K)
Nov 13, 2009 06:48 PM
- Form 4 ABBOTT LABORATORIES For: Nov 11 Filed by: Mason Heather L (10K)
Nov 13, 2009 06:47 PM
- Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: ALBAN CARLOS (10K)
Nov 04, 2009 05:49 PM
- Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: Mason Heather L (10K)
Nov 04, 2009 05:47 PM
- Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Warmuth Michael J (10K)
Oct 22, 2009 06:50 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ABT
|
Compare to S&P
|
| YTD |
1.33 %
|
-16.15 %
|
| 4 Weeks |
6.94 %
|
1.52 %
|
| 12 Weeks |
18.52 %
|
10.36 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 2.22 %
|
|
EPS Growth in Last Year: 16.46 %
|
|
Sales Growth in Last Quarter: 3.55 %
|
|
Sales Growth in Last Quarter: 3.51 %
|
|
